Literature DB >> 19684471

Allelic discrimination of genetic human prion diseases by real-time PCR genotyping.

Olga Calero1, Rafael Hortigüela, Carmen Albo, Jesés de Pedro-Cuesta, Miguel Calero.   

Abstract

The complete molecular characterization of human genetic prion diseases from different backgrounds is important for clinical diagnosis and epidemiological classification. The characterization of the PRNP gene should always include the description of the pathogenic mutation, as well as the status at each allele of the polymorphic codon 129 (M129V), a well-established susceptibility marker and phenotypic variability factor for different types of human prion diseases. Indeed, the phenotypical expression of two of the most common mutations in the human PRNP gene associated with genetic prion diseases, D178N and E200K, is clearly modulated by the codon 129 polymorphism. Here, we describe two simple, fast, cost-effective and suited for high-throughput protocols to resolve cis-trans ambiguities between these mutations respect the M129V polymorphism. This methodology is based on differential amplification by allele-specific primers using Real-time PCR monitored by SYBR Green dye. The main advantages of these protocols are their relative simplicity and the reduced cost compared to other methods such as cloning protocols, and that it may be readily applicable to the characterization of other mutations with codon 129-dependent expression, e.g., P102L.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19684471      PMCID: PMC2802779          DOI: 10.4161/pri.3.3.9339

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  14 in total

1.  Polymorphism at codon 129 of PRNP affects the phenotypic expression of Creutzfeldt-Jakob disease linked to E200K mutation.

Authors:  G Puoti; G Rossi; G Giaccone; T Awan; P M Lievens; C A Defanti; F Tagliavini; O Bugiani
Journal:  Ann Neurol       Date:  2000-08       Impact factor: 10.422

2.  Creutzfeldt-Jakob disease cosegregates with the codon 178Asn PRNP mutation in families of European origin.

Authors:  L G Goldfarb; P Brown; M Haltia; F Cathala; W R McCombie; J Kovanen; L Cervenáková; L Goldin; A Nieto; M S Godec
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

Review 3.  Prion diseases.

Authors:  J Collinge; M S Palmer
Journal:  Curr Opin Genet Dev       Date:  1992-06       Impact factor: 5.578

Review 4.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

5.  Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia.

Authors:  L G Goldfarb; E Mitrová; P Brown; B K Toh; D C Gajdusek
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

6.  Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene.

Authors:  K Basler; B Oesch; M Scott; D Westaway; M Wälchli; D F Groth; M P McKinley; S B Prusiner; C Weissmann
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

Review 7.  Molecular biology of prion diseases.

Authors:  S B Prusiner
Journal:  Science       Date:  1991-06-14       Impact factor: 47.728

8.  A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein.

Authors:  J A Hainfellner; P Parchi; T Kitamoto; C Jarius; P Gambetti; H Budka
Journal:  Ann Neurol       Date:  1999-06       Impact factor: 10.422

9.  Phenotypic variability in familial prion diseases due to the D178N mutation.

Authors:  J J Zarranz; A Digon; B Atarés; A B Rodríguez-Martínez; A Arce; N Carrera; I Fernández-Manchola; M Fernández-Martínez; C Fernández-Maiztegui; I Forcadas; L Galdos; J C Gómez-Esteban; A Ibáñez; E Lezcano; A López de Munain; J F Martí-Massó; M M Mendibe; M Urtasun; J M Uterga; N Saracibar; F Velasco; M M de Pancorbo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

10.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

View more
  5 in total

1.  Genetic variability of the gene cluster CALHM 1-3 in sporadic Creutzfeldt-Jakob disease.

Authors:  Olga Calero; María J Bullido; Jordi Clarimón; Rafael Hortigüela; Ana Frank-García; Pablo Martínez-Martín; Alberto Lleó; María Jesús Rey; Isabel Sastre; Alberto Rábano; Jesús de Pedro-Cuesta; Isidro Ferrer; Miguel Calero
Journal:  Prion       Date:  2012-08-09       Impact factor: 3.931

2.  A novel mutation I215V in the PRNP gene associated with Creutzfeldt-Jakob and Alzheimer's diseases in three patients with divergent clinical phenotypes.

Authors:  Mercedes Muñoz-Nieto; Neus Ramonet; Juan Ignacio López-Gastón; Natividad Cuadrado-Corrales; Olga Calero; Marcos Díaz-Hurtado; José Ramón Ipiens; Santiago Ramón y Cajal; Jesús de Pedro-Cuesta; Miguel Calero
Journal:  J Neurol       Date:  2012-07-05       Impact factor: 4.849

3.  Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases.

Authors:  Olga Calero; María J Bullido; Jordi Clarimón; Ana Frank-García; Pablo Martínez-Martín; Alberto Lleó; María Jesús Rey; Alberto Rábano; Rafael Blesa; Teresa Gómez-Isla; Fernando Valdivieso; Jesús de Pedro-Cuesta; Isidro Ferrer; Miguel Calero
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

4.  Medial Temporal Lobe Involvement in Human Prion Diseases: Implications for the Study of Focal Non Prion Neurodegenerative Pathology.

Authors:  Alberto Rábano; Carmen Guerrero Márquez; Ramón A Juste; María V Geijo; Miguel Calero
Journal:  Biomolecules       Date:  2021-03-10

5.  A common BACE1 polymorphism is a risk factor for sporadic Creutzfeldt-Jakob disease.

Authors:  Olga Calero; María J Bullido; Jordi Clarimón; Ana Frank-García; Pablo Martínez-Martín; Alberto Lleó; María Jesús Rey; Isabel Sastre; Alberto Rábano; Jesús de Pedro-Cuesta; Isidro Ferrer; Miguel Calero
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.